ctDNA Adds Specificity to PET Following Axicabtagene Ciloleucel in Large B-cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulating Tumor DNA Adds Specificity to PET following Axicabtagene Ciloleucel in Large B-cell Lymphoma
Blood Adv 2023 May 01;[EPub Ahead of Print], EA Dean, GJ Kimmel, MJ Frank, A Bukhari, NM Hossain, MD Jain, S Dahiya, DB Miklos, PM Altrock, FL LockeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.